Company: MIRA
Filing Date: 2025-06-17
Form Type: PREM14A
Source: 0001641172-25-015340
Chunk: 22

Company: MIRA PHARMACEUTICALS, INC.
Filing Date: 2025-06-17
Form: PREM14A
Chunk 22
---
                        
 or regulatory reform of the health care system in the U.S. may affect SKNY’s ability               
 to profitably sell its products, if approved.                                                      |
| ● | SKNY’s                                                                                             
 directors and executive officers and MIRA’s directors and officers have interests in               
 the Merger that may be different from, or in addition to, the interests of SKNY stockholders       
 generally and the interests of MIRA stockholders generally.                                        |
| ● | Each                                                                                               
 of MIRA and SKNY are subject to various uncertainties, including contractual restrictions          
 and requirements while the Merger is pending, that could adversely affect their businesses,        
 financial condition and results of operations.                                                     |
| ● | Litigation                                                                                         
 relating to the Transaction may be filed against the MIRA Board that could result in substantial   
 costs or delay or prevent the completion of the Transaction.                                       |
| ● | If                                                                                                 
 MIRA is determined to be an investment company under the U.S. Investment Company Act of 1940,      
 applicable restrictions could make it impractical for to continue with the Transaction and         
 could adversely affect MIRA’s business, financial condition or results of operations.              |

MIRA Virtual Special Meeting (see page 38) The MIRA virtual special meeting will be held exclusively online via audio-only webcast on at Eastern Time, unless postponed or adjourned to a later date. The virtual special meeting can be accessed by visiting www.voteproxy.com, where you will be able to vote your shares and submit questions during the MIRA virtual special meeting webcast by logging in to the website listed above using the control number included in your proxy card. Online check-in will begin at Eastern Time, and we encourage you to allow ample time for the online check-in procedures. Please note that you will not be able to attend the MIRA virtual special meeting in person.

| 10 |

<div align='center'>MARKET PRICE AND DIVIDEND INFORMATION</div>

MIRA Common Stock is currently listed on The Nasdaq Global Market under the symbol “MIRA.” SKNY is a private company and the shares of SKNY Capital Stock are not publicly traded.

MIRA Common Stock

The closing price of MIRA Common Stock on March 18, 2025, the trading day immediately prior to the public announcement of the Merger on March 19, 2025, as reported on The Nasdaq Global Market, was $1.17 per share. The closing price of MIRA Common Stock on March